📣 VC round data is live. Check it out!

Odinwell Valuation Multiples

Discover revenue and EBITDA valuation multiples for Odinwell and similar public comparables like S2Medical, Audientes, Standard Dental Labs, Momina Krepost and more.

Odinwell Overview

About Odinwell

Odinwell AB is a medtech company with a patented optical technology for assessment of covered wounds.


Founded

N/A

HQ

Sweden

Employees

N/A

Financials (FY)

Revenue:
EBITDA: ($507K)

EV

$647K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Odinwell Financials

Odinwell reported last fiscal year revenue of — and negative EBITDA of ($507K).

In the same fiscal year, Odinwell generated $426K in gross profit, ($507K) in EBITDA losses, and had net loss of ($625K).


Odinwell P&L

In the most recent fiscal year, Odinwell reported revenue of and EBITDA of ($507K).

Odinwell is unprofitable as of last fiscal year, with gross margin of —, EBITDA margin of —, and net margin of —.

See analyst estimates for Odinwell
Last FY202320242025202620272028
Gross Profit$426K$443K$503K$426K
EBITDA($507K)($532K)($444K)($507K)
Net Profit($625K)($636K)($559K)($625K)

Financial data powered by Morningstar, Inc.

Odinwell Stock Performance

Odinwell has current market cap of $1M, and enterprise value of $647K.

Market Cap Evolution


Odinwell's stock price is $0.02.

Odinwell share price decreased by 7.1% in the last 30 days, and by 43.0% in the last year.

Odinwell has an EPS (earnings per share) of $-0.01.

See more trading valuation data for Odinwell
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$647K$1M-5.7%-7.1%-7.1%-43.0%$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Odinwell Valuation Multiples

Odinwell trades at (1.3x) EV/EBITDA.

See NTM and 2027E valuation multiples for Odinwell

Odinwell Financial Valuation Multiples

As of May 20, 2026, Odinwell has market cap of $1M and EV of $647K.

Odinwell has a P/E ratio of (1.8x).

Last FY202320242025202620272028
EV/EBITDA(1.3x)(1.2x)(1.5x)(1.3x)
EV/EBIT(1.0x)(0.9x)(0.9x)(1.0x)
EV/Gross Profit1.5x1.5x1.3x1.5x
P/E(1.8x)(1.8x)(2.0x)(1.8x)
EV/FCF(0.6x)(0.6x)(0.6x)(0.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Odinwell Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Odinwell Margins & Growth Rates

See estimated margins and future growth rates for Odinwell

Odinwell Growth Rates

23/2424/2526/2727/2828/29
Gross Profit Growth14%(15%)
EBITDA Growth(17%)14%
EBIT Growth(8%)(5%)
Net Profit Growth(12%)12%
FCF Growth2%(12%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Odinwell Competitors

Odinwell competitors include S2Medical, Audientes, Standard Dental Labs, Momina Krepost, Cuprina Holdings (Cayman), BioRegenx, Airway Medix, Etropal, iZafe Group and Balsm Alofoq.

Most Odinwell public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
S2Medical0.3x(0.5x)
Audientes
Standard Dental Labs
Momina Krepost5.5x(5.2x)
Cuprina Holdings (Cayman)94.8x(1.0x)
BioRegenx
Airway Medix11589.3x13.3x
Etropal1.4x17.9x

This data is available for Pro users. Sign up to see all Odinwell competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Odinwell

Where is Odinwell headquartered?Odinwell is headquartered in Sweden.
Is Odinwell publicly listed?Yes, Odinwell is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Odinwell?Odinwell trades under ODIN ticker.
When did Odinwell go public?Odinwell went public in 2021.
Who are competitors of Odinwell?Odinwell main competitors include S2Medical, Audientes, Standard Dental Labs, Momina Krepost, Cuprina Holdings (Cayman), BioRegenx, Airway Medix, Etropal, iZafe Group, Balsm Alofoq.
What is the current market cap of Odinwell?Odinwell's current market cap is $1M.
Is Odinwell profitable?No, Odinwell is not profitable.
How many companies Odinwell has acquired to date?Odinwell hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Odinwell has invested to date?Odinwell hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Odinwell

Lists including Odinwell

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial